AMORPHOUS DERIVATIVE OF PYRROLIDINE AS PPAR AGONIST AND METHOD FOR PRODUCTION THEREOF
FIELD: chemistry.SUBSTANCE: invention relates to an amorphous form of the compound represented by the formula (I) wherein the powder X-ray diffractogram of the amorphous form does not have any sharp diffraction peak and has a wide reclined diffraction peak at an angle of 2θ between 10° and 25°, as w...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CHZHO, Vejsyan KHE, Khajin SYUJ, Tsziven TSZYAN, Chzhigan YUJAN, Chzhilyan CHEN, Shukhoj LI, Tszyan CHZHAN, Syao |
| description | FIELD: chemistry.SUBSTANCE: invention relates to an amorphous form of the compound represented by the formula (I) wherein the powder X-ray diffractogram of the amorphous form does not have any sharp diffraction peak and has a wide reclined diffraction peak at an angle of 2θ between 10° and 25°, as well as to a method of production thereof.EFFECT: new amorphous form of the compound represented by the formula (I) is produced which can be used as a PPAR agonist, wherein the amorphous form is characterized by significant stability.7 cl, 3 dwg, 5 tbl, 3 ex
Изобретение относится к аморфной форме соединения, представленного формулой (I), причем порошковая рентгеновская дифрактограмма аморфной формы не имеет какого-либо острого дифракционного пика и имеет широкий и пологий дифракционный пик при значении угла 2θ от 10° до 25°, а также к способу его получения. Технический результат: получена новая аморфная форма соединения, представленного формулой (I), которая может быть использована в качестве агониста PPAR, причем аморфная форма характеризуется значительной стабильностью. 2 н. и 5 з.п. ф-лы, 3 ил., 5 табл., 3 пр. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2749056C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2749056C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2749056C13</originalsourceid><addsrcrecordid>eNqNyjsKAjEQANA0FqLeYS4g-F8sQzIxA24mTJIFq2WRWIkurPfHxgNYvebNVdEtS_RcElgU6nSmDoEdxJsIX8lSQNAJYtQC-sKBUgYdLLSYPVtwLBCFbTGZOED2KMhuqWaP4TnV1c-FAofZ-HUd332dxuFeX_XTS9k1h_PmeDLb_R_lCymnMHA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMORPHOUS DERIVATIVE OF PYRROLIDINE AS PPAR AGONIST AND METHOD FOR PRODUCTION THEREOF</title><source>esp@cenet</source><creator>CHZHO, Vejsyan ; KHE, Khajin ; SYUJ, Tsziven ; TSZYAN, Chzhigan ; YUJAN, Chzhilyan ; CHEN, Shukhoj ; LI, Tszyan ; CHZHAN, Syao</creator><creatorcontrib>CHZHO, Vejsyan ; KHE, Khajin ; SYUJ, Tsziven ; TSZYAN, Chzhigan ; YUJAN, Chzhilyan ; CHEN, Shukhoj ; LI, Tszyan ; CHZHAN, Syao</creatorcontrib><description>FIELD: chemistry.SUBSTANCE: invention relates to an amorphous form of the compound represented by the formula (I) wherein the powder X-ray diffractogram of the amorphous form does not have any sharp diffraction peak and has a wide reclined diffraction peak at an angle of 2θ between 10° and 25°, as well as to a method of production thereof.EFFECT: new amorphous form of the compound represented by the formula (I) is produced which can be used as a PPAR agonist, wherein the amorphous form is characterized by significant stability.7 cl, 3 dwg, 5 tbl, 3 ex
Изобретение относится к аморфной форме соединения, представленного формулой (I), причем порошковая рентгеновская дифрактограмма аморфной формы не имеет какого-либо острого дифракционного пика и имеет широкий и пологий дифракционный пик при значении угла 2θ от 10° до 25°, а также к способу его получения. Технический результат: получена новая аморфная форма соединения, представленного формулой (I), которая может быть использована в качестве агониста PPAR, причем аморфная форма характеризуется значительной стабильностью. 2 н. и 5 з.п. ф-лы, 3 ил., 5 табл., 3 пр.</description><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210603&DB=EPODOC&CC=RU&NR=2749056C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210603&DB=EPODOC&CC=RU&NR=2749056C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHZHO, Vejsyan</creatorcontrib><creatorcontrib>KHE, Khajin</creatorcontrib><creatorcontrib>SYUJ, Tsziven</creatorcontrib><creatorcontrib>TSZYAN, Chzhigan</creatorcontrib><creatorcontrib>YUJAN, Chzhilyan</creatorcontrib><creatorcontrib>CHEN, Shukhoj</creatorcontrib><creatorcontrib>LI, Tszyan</creatorcontrib><creatorcontrib>CHZHAN, Syao</creatorcontrib><title>AMORPHOUS DERIVATIVE OF PYRROLIDINE AS PPAR AGONIST AND METHOD FOR PRODUCTION THEREOF</title><description>FIELD: chemistry.SUBSTANCE: invention relates to an amorphous form of the compound represented by the formula (I) wherein the powder X-ray diffractogram of the amorphous form does not have any sharp diffraction peak and has a wide reclined diffraction peak at an angle of 2θ between 10° and 25°, as well as to a method of production thereof.EFFECT: new amorphous form of the compound represented by the formula (I) is produced which can be used as a PPAR agonist, wherein the amorphous form is characterized by significant stability.7 cl, 3 dwg, 5 tbl, 3 ex
Изобретение относится к аморфной форме соединения, представленного формулой (I), причем порошковая рентгеновская дифрактограмма аморфной формы не имеет какого-либо острого дифракционного пика и имеет широкий и пологий дифракционный пик при значении угла 2θ от 10° до 25°, а также к способу его получения. Технический результат: получена новая аморфная форма соединения, представленного формулой (I), которая может быть использована в качестве агониста PPAR, причем аморфная форма характеризуется значительной стабильностью. 2 н. и 5 з.п. ф-лы, 3 ил., 5 табл., 3 пр.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjsKAjEQANA0FqLeYS4g-F8sQzIxA24mTJIFq2WRWIkurPfHxgNYvebNVdEtS_RcElgU6nSmDoEdxJsIX8lSQNAJYtQC-sKBUgYdLLSYPVtwLBCFbTGZOED2KMhuqWaP4TnV1c-FAofZ-HUd332dxuFeX_XTS9k1h_PmeDLb_R_lCymnMHA</recordid><startdate>20210603</startdate><enddate>20210603</enddate><creator>CHZHO, Vejsyan</creator><creator>KHE, Khajin</creator><creator>SYUJ, Tsziven</creator><creator>TSZYAN, Chzhigan</creator><creator>YUJAN, Chzhilyan</creator><creator>CHEN, Shukhoj</creator><creator>LI, Tszyan</creator><creator>CHZHAN, Syao</creator><scope>EVB</scope></search><sort><creationdate>20210603</creationdate><title>AMORPHOUS DERIVATIVE OF PYRROLIDINE AS PPAR AGONIST AND METHOD FOR PRODUCTION THEREOF</title><author>CHZHO, Vejsyan ; KHE, Khajin ; SYUJ, Tsziven ; TSZYAN, Chzhigan ; YUJAN, Chzhilyan ; CHEN, Shukhoj ; LI, Tszyan ; CHZHAN, Syao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2749056C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHZHO, Vejsyan</creatorcontrib><creatorcontrib>KHE, Khajin</creatorcontrib><creatorcontrib>SYUJ, Tsziven</creatorcontrib><creatorcontrib>TSZYAN, Chzhigan</creatorcontrib><creatorcontrib>YUJAN, Chzhilyan</creatorcontrib><creatorcontrib>CHEN, Shukhoj</creatorcontrib><creatorcontrib>LI, Tszyan</creatorcontrib><creatorcontrib>CHZHAN, Syao</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHZHO, Vejsyan</au><au>KHE, Khajin</au><au>SYUJ, Tsziven</au><au>TSZYAN, Chzhigan</au><au>YUJAN, Chzhilyan</au><au>CHEN, Shukhoj</au><au>LI, Tszyan</au><au>CHZHAN, Syao</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMORPHOUS DERIVATIVE OF PYRROLIDINE AS PPAR AGONIST AND METHOD FOR PRODUCTION THEREOF</title><date>2021-06-03</date><risdate>2021</risdate><abstract>FIELD: chemistry.SUBSTANCE: invention relates to an amorphous form of the compound represented by the formula (I) wherein the powder X-ray diffractogram of the amorphous form does not have any sharp diffraction peak and has a wide reclined diffraction peak at an angle of 2θ between 10° and 25°, as well as to a method of production thereof.EFFECT: new amorphous form of the compound represented by the formula (I) is produced which can be used as a PPAR agonist, wherein the amorphous form is characterized by significant stability.7 cl, 3 dwg, 5 tbl, 3 ex
Изобретение относится к аморфной форме соединения, представленного формулой (I), причем порошковая рентгеновская дифрактограмма аморфной формы не имеет какого-либо острого дифракционного пика и имеет широкий и пологий дифракционный пик при значении угла 2θ от 10° до 25°, а также к способу его получения. Технический результат: получена новая аморфная форма соединения, представленного формулой (I), которая может быть использована в качестве агониста PPAR, причем аморфная форма характеризуется значительной стабильностью. 2 н. и 5 з.п. ф-лы, 3 ил., 5 табл., 3 пр.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2749056C1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AMORPHOUS DERIVATIVE OF PYRROLIDINE AS PPAR AGONIST AND METHOD FOR PRODUCTION THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A08%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHZHO,%20Vejsyan&rft.date=2021-06-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2749056C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |